SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to MDS
Related studies linked through entity extraction aliases.
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Pacritinib With Aza for Upfront Myelodysplastic Syndrome
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Quality of Life-Guided Transfusion in Refractory MDS or AML
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety of HMAs Combined With Venetoclax Versus HMAs Alone in ND Int-and H-risk MDS or CMML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
- Status
- RECRUITING
- Phase
- N/A
QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Reduced Intensity Conditioning for MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia Patients
- Status
- RECRUITING
- Phase
- N/A
A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
- Status
- RECRUITING
- Phase
- PHASE1
A Long Term Follow-up Study of TScan TCR-T Products
- Status
- RECRUITING
- Phase
- N/A
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
- Status
- RECRUITING
- Phase
- N/A
Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation
- Status
- RECRUITING
- Phase
- PHASE2
BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2